Mycodern (WAR:MCD) YoY EPS Growth: 0.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:MCD Mycodern SA WAR:MCD
30 GF Score
Price zł0.78
! 2 Warning Signs
View Full Analysis

What is Mycodern YoY EPS Growth?

Mycodern WAR:MCD 30 YoY EPS Growth is 0.00% as of Jun. 2026. GuruFocus rates WAR:MCD with a GF Score™ of 30/100. The stock has 2 warning signs investors should review.

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Mycodern's YoY EPS Growth for the quarter that ended in Jun. 2026 was 0.00%.

Mycodern's Earnings per Share (Diluted) for the six months ended in Jun. 2026 was zł-0.01.

Mycodern YoY EPS Growth Historical Data

* Premium members only.

The historical data trend for Mycodern's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mycodern YoY EPS Growth Chart

Mycodern Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,673.33 98.87 83.33 -46,600.00 99.14

Mycodern Semi-Annual Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
WAR:MCD
30GF Score
Mycodern SA WAR:MCD
YoY EPS Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mycodern YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Mycodern's YoY EPS Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EPS Growth (A: Dec. 2025 )
=(Earnings per Share (Diluted) (A: Dec. 2025 )-Earnings per Share (Diluted) (A: Dec. 2024 ))/ | Earnings per Share (Diluted) (A: Dec. 2024 ) |
=(-0.004--0.467)/ | -0.467 |
=99.14 %

Mycodern's YoY EPS Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EPS Growth (Q: Jun. 2026 )
=(Earnings per Share (Diluted) (Q: Jun. 2026 )-Earnings per Share (Diluted) (Q: Mar. 2026 )) / | Earnings per Share (Diluted) (Q: Mar. 2026 ) |
=(-0.006--0)/ | -0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EPS Growth →
What does a YoY EPS Growth of 0.00% mean?
Mycodern (WAR:MCD) has a YoY EPS Growth of 0.00% as of Jun. 2026. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Mycodern and its competitors.
Is Mycodern's YoY EPS Growth too high?
Mycodern's current YoY EPS Growth is 0.00%. Overall, Mycodern has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Mycodern's YoY EPS Growth compare to KHC and GIS?
Mycodern's YoY EPS Growth of 0.00% can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EPS Growth for a Consumer Packaged Goods company?
A good YoY EPS Growth depends on the Consumer Packaged Goods industry context. However, YoY EPS Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EPS Growth mean?
A high YoY EPS Growth can signal that a stock is expensive relative to its fundamentals. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Mycodern and its competitors. Mycodern's current YoY EPS Growth is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mycodern stock overvalued right now?
Mycodern (WAR:MCD) has a current YoY EPS Growth of 0.00%. The current YoY EPS Growth is 0.00%. Mycodern's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EPS Growth calculated?
YoY EPS Growth is calculated from a company's financial statements. For Mycodern (WAR:MCD), the current YoY EPS Growth is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mycodern Business Description

Address Kartuska 213, Gdansk, POL, 80-122
Mycodern SA is a Polish company operating in the functional food and dietary supplement sector. It develops, produces, and sells food products and supplements positioned around health, wellness, and nutrition, with a focus on functional ingredients. Its portfolio spans functional foods and innovative supplement formulations aimed at consumers seeking health-oriented dietary options. The company serves the Polish market and broader European retail and distribution channels, selling through grocery, pharmacy, and specialty health-food outlets as well as online channels. Revenue is generated primarily from the sale of its own branded food and supplement products, supplemented by private-label or contract manufacturing arrangements where applicable. As a relatively small player in the European functional food space, Mycodern competes with larger domestic and international supplement and health-food manufacturers. The company emphasizes product quality and formulation innovation as core elements of its market positioning.
30GF Score

Get the complete analysis for WAR:MCD

YoY EPS Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.78
Price